Grants for Public housing authorities - Health

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA (see RFA-HL-22-011).

The Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) aims to support licensed neurologists and neurosurgeons in the NINDS intramural program as they transition to independent academic positions while leading clinical trials and advancing their research careers in neuroscience.

This funding opportunity supports research projects that investigate the long-term impacts of disasters on healthcare systems serving vulnerable populations in the U.S., aiming to improve access and reduce health disparities.

This funding opportunity supports U.S.-based small businesses in the clinical validation of biomarkers for neurological or neuromuscular disorders, promoting inclusivity and collaboration while ensuring rigorous scientific standards for potential diagnostic and therapeutic applications.

Reissue of PAR-20-118. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA using the U01 mechanism supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies Projects seeking support for a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach should consider the companion U19 FOA.

This grant provides funding for research studies that explore the relationship between autophagy, HIV infection, and substance use disorders, aiming to uncover mechanisms that could lead to new therapeutic strategies for affected individuals.

This funding opportunity provides resources to support global health initiatives aimed at preventing, detecting, and responding to public health threats in collaboration with health ministries and governmental institutions worldwide.

Grant Opportunity: Community Foundation of Frederick County Rolling Grants Funding Organization: The Community Foundation of Frederick County Contact Information: For questions, email [email protected] or call 301.695.7660. Award Details: The Rolling Grant program provides grants for any purpose, including a wide range of field of interest and special purpose funds, and support for individuals served by nonprofits or government agencies. The minimum grant request is $500, and the maximum request varies by fund. Grants must provide direct benefits to Frederick County, Maryland residents unless otherwise noted in the fund description. Eligibility: Eligible organizations include already existing nonprofit 501c3 organizations in good standing with the IRS, government/quasi-governmental agencies applying for extraordinary projects not funded by tax revenue, religious organizations requesting funding for non-sectarian activities, and civic groups that are not 501c3 organizations requesting funding for a community cause. All applicants must meet Maryland's nonprofit requirements. Application Process: Organizations can submit grant applications through Foundant, the online grants management system used by The Community Foundation. Multiple applications are permitted, with one application per fund to which the organization is applying. Additional Information: Applications can be modified until the application deadline. Grant funds are generally disbursed in full during the first month of the grant period, except for civic organizations that receive reimbursement based on proof of expense and addressing the approved community cause. Variance requests to modify budget or program services can be made before the end of the grant period but require approval from the Community Foundation's Board of Trustees. Multi-year funding is not provided at this time. For more information and to access the application portal, visit this link: [https://www.grantinterface.com/Home/Logon?ReturnUrl=%2fProcess%2fShortLinkApply%3fprocessGuid%3ddf0970bb-29dc-4f89-a69a-b5e2e780c6dd%26UrlKey%3dfrederickcounty&processGuid=df0970bb-29dc-4f89-a69a-b5e2e780c6dd&UrlKey=frederickcounty]

This funding opportunity provides financial support for research projects that evaluate effective strategies to prevent child sexual abuse and problematic sexual behavior among youth, particularly through community partnerships and addressing health equity.

This funding opportunity supports educational programs that provide research experiences for undergraduate students from diverse backgrounds to encourage their pursuit of careers in aging-related research.

The National Cancer Institute (NCI) intends to issue a notice of funding opportunity (NOFO) for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialists Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigator of research project grants. This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications. Applications are limited to four per institution per receipt date including new (A0) and resubmissions (A1). NCI-designated cancer center consortia are considered one institution. NCI seeks a broad representation of institutions for this award mechanism and may take this into account when making funding decisions. The NOFO is expected to be published in late summer 2024 with only one expected application due date of November 5, 2024.

This grant provides funding for research projects that explore how climate change affects cancer risks and care, particularly focusing on vulnerable populations and aiming to reduce health disparities.

This funding opportunity provides financial support to public and nonprofit organizations to deliver comprehensive primary health care services in underserved communities across the United States.

This program provides one-time funding to nursing homes and assisted living facilities in Nebraska to create intergenerational childcare spaces that promote interaction between seniors and children.

This funding opportunity supports research that investigates how sex and gender differences impact health outcomes and disease management, targeting a wide range of eligible organizations, including universities and nonprofits.

This funding opportunity supports a variety of organizations in developing and testing new clinical applications derived from basic research to improve health outcomes for individuals with communication disorders.

The purpose of the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.

The National Institute on Alcohol Abuse and Alcoholism ( NIAAA) intends to reissue RFA-AA-23-001, Specialized Alcohol Research Centers (P50, Clinical Trial Optional), by publishing a NOFO to solicit applications for a broad-based Alcohol Research Centers program to foster and conduct interdisciplinary, collaborative research on Alcohol Use Disorder (AUD), alcohol misuse and alcohol-related problems, and other health-related consequences across the lifespan. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Fall 2024. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To support innovative and novel research across the vast NIH mission, individuals from diverse backgrounds (including those from underrepresented groups; see Notice of NIHs Interest in Diversity) and from the full spectrum of eligible institutions in all geographic locations are encouraged to apply to this Notice of Funding Opportunity. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

This funding opportunity provides financial support to organizations implementing strategies to prevent diabetes and improve health equity for populations at risk, focusing on statewide, local, or multisectoral approaches.